Correlation Between Immunome and In8bio
Can any of the company-specific risk be diversified away by investing in both Immunome and In8bio at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Immunome and In8bio into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Immunome and In8bio Inc, you can compare the effects of market volatilities on Immunome and In8bio and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Immunome with a short position of In8bio. Check out your portfolio center. Please also check ongoing floating volatility patterns of Immunome and In8bio.
Diversification Opportunities for Immunome and In8bio
Very weak diversification
The 3 months correlation between Immunome and In8bio is 0.49. Overlapping area represents the amount of risk that can be diversified away by holding Immunome and In8bio Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on In8bio Inc and Immunome is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Immunome are associated (or correlated) with In8bio. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of In8bio Inc has no effect on the direction of Immunome i.e., Immunome and In8bio go up and down completely randomly.
Pair Corralation between Immunome and In8bio
Given the investment horizon of 90 days Immunome is expected to under-perform the In8bio. But the stock apears to be less risky and, when comparing its historical volatility, Immunome is 1.36 times less risky than In8bio. The stock trades about -0.11 of its potential returns per unit of risk. The In8bio Inc is currently generating about -0.05 of returns per unit of risk over similar time horizon. If you would invest 27.00 in In8bio Inc on December 29, 2024 and sell it today you would lose (7.00) from holding In8bio Inc or give up 25.93% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Weak |
Accuracy | 100.0% |
Values | Daily Returns |
Immunome vs. In8bio Inc
Performance |
Timeline |
Immunome |
In8bio Inc |
Immunome and In8bio Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Immunome and In8bio
The main advantage of trading using opposite Immunome and In8bio positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Immunome position performs unexpectedly, In8bio can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in In8bio will offset losses from the drop in In8bio's long position.Immunome vs. Anebulo Pharmaceuticals | Immunome vs. Adagene | Immunome vs. Acrivon Therapeutics, Common | Immunome vs. AnaptysBio |
In8bio vs. Reviva Pharmaceuticals Holdings | In8bio vs. Cue Biopharma | In8bio vs. Lantern Pharma | In8bio vs. Anixa Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.
Other Complementary Tools
Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Fundamentals Comparison Compare fundamentals across multiple equities to find investing opportunities |